WHO ICTRP trial
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design…
ACTRN12606000314527 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12606000314527 |
|---|---|
| Public title | A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung Cancer or Esophageal Cancer |
| Scientific title | A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung Cancer or Esophageal Cancer |
| Primary sponsor | Bayer Australia Limited |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Australia |
| Conditions | Lung Cancer or Esophageal Cancer; Lung Cancer or Esophageal Cancer;Cancer - Oesophageal (gullet);Cancer - Lung - Mesothelioma;Cancer - Lung - Non small cell;Cancer - Lung - Small cell |
| Interventions | This trial is a randomized, double-blind, multi-center, 2 arm, parallel design study of aprotinin (Trasylol) versus placebo in subjects undergoing selected surgeries on the lung consisting of planned complete primary pneumonectomy or other… |
| Registration date | Jul 21, 2006 |
| Target size | 696 |
| Secondary IDs | ClinicalTrials.gov: NCT00306137 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: